BUZZ-Street View: UnitedHealth bucks the healthcare blues
UNH•Brokers point to stronger confidence in the outlook
** J.P. Morgan ("overweight") says UnitedHealth's diversification and scale increase confidence in co's ability to sustain its long-term growth trajectory beyond 2027
** Morgan Stanley ("overweight," PT: $529) says UNH's strong Q2 performance and higher 2026 targets validate its strategy and set a solid foundation for growth
** Adds, while rising commercial costs remain a risk, improving trends in Medicare Advantage and Optum Health support a more positive outlook for the rest of the year
** Morningstar (fair value: $475) says co continues to have significant capacity to absorb operational challenges or regulatory changes before its long-term ability to generate economic profits would be impaired
** Oppenheimer ("outperform," PT: $500) says the results reinforce its long-term confidence in UNH, cementing its status as the premier blue chip co in the sector
UnitedHealth posts better-than-expected second-quarter profit expectations and lifts 2026 outlook
** UnitedHealth Group UNH.N on Thursday posted better-than-expected second-quarter profit expectations and lifted its 2026 outlook, benefiting from improved control over medical costs
** Median PT of 30 brokerages covering the stock is $470 — LSEG-compiled data
